AKAndrey A. Kalemberg

Andrey A. Kalemberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrey A. Kalemberg has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The impact of training image quality with a novel protocol on artificial intelligence-based LGE-MRI image segmentation for potential atrial fibrillation management

    by A.K. Berezhnoy, A.I. Kalinin, D.A. Parshin, A.S. Selivanov, A.G. Demin, A.G. Zubov, R.S. Shaidullina, A.A. Aitova, M.M. Slotvitsky, A.A. Kalemberg, et al.


  • Open Access

    Adverse effects of intracardiac dyssynchrony and right ventricular pacing on contractile function and prognosis

    by D. Yu. Andreev, M. G. Glezer, A. A. Kalemberg

    Pacemaker-induced cardiomyopathy (PICM) is a complication of frequent right ventricular pacing, which in most studies is regarded as a decrease in the left ventricular ejection fraction with constant right ventricular pacing. However, cases of PICM with preserved left ventricular ejection fraction are insufficiently described, since the onset most often occurs as a phenotype of heart failure with preserved ejection fraction. The paper analyzes the studies on the role of constant right ventricular pacing and its contribution to PICM development.


  • Open Access

    Modeling the functional heterogeneity and conditions for the occurrence of microreentry in procedurally created atrial fibrous tissue

    by Aleksey Kalinin, Vadim Naumov, Sandaara Kovalenko, Andrey Berezhnoy, Mihail Slotvitsky, Serafima Scherbina, Aleria Aitova, Vladimir Syrovnev, Mikhail Popov, Andrey Kalemberg, et al.

    The occurrence of atrial fibrillation (AF), one of the most socially significant arrhythmias, is associated with the presence of areas of fibrosis. Fibrosis introduces conduction heterogeneity into the cardiac tissue and, thus, may be a substrate for spiral wave reentry, which provokes the onset of AF and is often associated with its persistence. Despite results from computer and animal models of cardiac tissues, data on the conditions under which microreentries occur in human tissues are limited. In this work, we conducted a study of the new approach to modeling the fibrous atrial tissue, which takes into account the cellular structure and conduction in fibrosis areas. Using the Potts model, we created a realistic texture of atrial tissues remodeled by fibroblasts and showed the presence of pathways in such a system with a low proportion of fibroblasts. Our study revealed the relationship between the shape of the cells’ action potential, their location in the tissue, and the direction of the wave propagation. The wavefront obtained in the model creates a dynamic heterogeneity of the tissue, which affects the migration and pinning of spiral waves, and explains the formation of microreentries in the cardiac tissue. In the future, such a model can become a potential tool for predictive modeling of AF and the search for ablation target identification.


  • Open Access

    Shortened PQ interval in the differential diagnosis of Anderson-Fabry disease: a case report

    by P. D. Zlobina, A. A. Kalemberg, R. P. Myasnikov, M. S. Kharlap, O. V. Kulikova, E. A. Mershina, A. V. Tarasov, K. V. Davtyan

    In this article, we present a case of a patient with a late diagnosis of Fabry disease caused by a pathogenic variant in the GLA gene (p.1287_1288dup), who repeatedly attempted interventional treatment of Wolff-Parkinson-White Syndrome due to characteristic electrocardiographic pattern of ventricular preexcitation and paroxysmal arrhythmias. The proposed pathognomonic signs of the disease will ensure timely diagnosis and the appointment of specific treatment.


  • Open Access

    Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation

    by T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg

    Objective: to evaluate cost-effectiveness and budget impact of using single and dual chamber implantable cardioverter-defibrillators (ICD) adjunctive to the standard drug therapy (DT) compared to the standard DT alone for the primary and secondary prevention of sudden cardiac death (SCD).Material and methods. Original partitioned survival analysis model was developed to assess the cost-effectiveness of using ICD within the modelling horizon of 8 years. The following model outcomes were used: life years and quality-adjusted life years (QALY). Primary prevention model was focused on patients after myocardial infarction with left ventricular ejection fraction (LVEF) ≤30%, whilst secondary prevention model considered cardiac arrest survivors and/or patients diagnosed with ventricular tachycardia or ventricular fibrillation with LVEF ≤35%. The model summarizes treatment effect and costs for ICD and DT specific to the healthcare system of the Russian Federation (RF). The main scenario accounted for ICD implantation cost in accordance with general reimbursement price asserted in the high technology medical care list part 2 (HТMC 2). Additionally, alternative scenario of ICD reimbursement level was developed to account for general tariff split onto singleand dual-chamber ICD implantation reimbursement tariffs which can be financed through high technology medical care list part 1 (HТMC 1). Budget impact analysis compared the costs of using ICD within the current volume of the annual increase in ICD implantations and a threefold increased volume of ICD implantations.Results. By the end of the modelling period, additional 34% of patients survived in the ICD group compared to the DT group. Incremental cost-effectiveness ratio (ICER) per 1 QALY constituted 2.8 and 2.2 million rubles for primary and secondary prevention, respectively. ICER values are slightly above or lower than the willingness-to-pay threshold of 2.5 million rubles per 1 QALY in the RF in the segment of primary and secondary SCD prevention, respectively. Additional HТMC 1 scenario incorporating lower ICD implantation prices resulted in an average ICER drop by 13% compared to HTMC 2. Overall patient population requiring SCD prevention comprised of 7,161 and 3,341 patients in primary and secondary prevention, respectively. Budget impact analysis showed that threefold rise in the ICD implantations rate will require additional 648 million rubles for primary prevention cohort to provide additional 573 patients with ICD, and 230 million rubles for secondary prevention cohort with additional 267 patients covered with ICD. ICD reimbursement price drop within the HТMC 1 scenario will save 133 million rubles and allow to provide additional 143 patients with ICDs for a given budget.Conclusion. ICD is a cost-effective option of secondary prevention of SCD. Additional analysis of ICD reimbursement price drop drives ICER downwards to a considerable extent which in turn increases the accessibility of ICDs to patients. In scenario of ICD implantation financing within HТMC 1, ICD is established to be a cost-effective option for primary and secondary prevention of SCD in the RF.


  • Open Access

    The predictive role of early recurrences of atrial arrhythmias after pulmonary vein cryoballoon ablation. Is blanking period an outdated concept? Insights from 12-month continuous cardiac monitoring

    by Karapet V. Davtyan, Arpi H. Topchyan, Hakob A. Brutyan, Elena N. Kalemberg, Maria S. Kharlap, Georgiy Yu. Simonyan, Andrey A. Kalemberg, Maria V. Kuznetsova

    Background: Early recurrences of atrial arrhythmias (ERAA) after atrial fibrillation (AF) catheter ablation do not predict procedural failure. A well-demarcated homogeneous lesion delivered by cryoballoon is less arrhythmogenic, and the recommended three-months blanking period may not refer to cryoballoon ablation (CBA). Objective: We aimed to evaluate the predictive role of ERAA after second-generation CBA using an implantable loop recorder. Methods: This prospective observational study enrolled 100 patients (58 males, median age 58) with paroxysmal/persistent AF undergoing pulmonary vein (PV) CBA using second-generation cryoballoon with simultaneous ECG loop recorder implantation. The duration of follow-up was 12 months, with scheduled visits at 3, 6 and 12 months. Results: 99 patients from 100 completed the 12-month follow-up period. ERAA occurred in 31.3 % of patients. 83.9 % of patients with ERAA also developed late recurrences. The 12-month freedom from AF in patients with ERAA was significantly lower than in those without ERAA (p < 0.0001). Non-paroxysmal AF and longer arrhythmia history were associated with increased risk of both early (HR 3.27; 95 % CI 1.32–8.08; p = 0.010 and HR 1.0147; 95 % CI 1.008–1.086; p = 0.015, respectively) and late recurrences (HR 3.89; 95 % CI 1.67–9.04; p = 0.002 and HR 1.0142; 95 % CI 1.007–1.078; p = 0.019, respectively) of AF. ERAA were another predictor for procedural failure (HR 15.2; 95 % CI (6.42–35.99; p = 0.019). Conclusions: ERAA occurred in the third of the patients after PV second-generation CBA and are strongly associated with procedural failure. Longer duration of AF history and persistent AF are independent predictors of AF’s early and late recurrence.


  • Open Access

    Relationship between serum inflammatory markers and recurrent atrial fibrillation in patients undergoing pulmonary vein isolation

    by E. N. Tsareva, K. V. Davtyan, A. G. Topchyan, M. S. Kharlap, A. A. Kalemberg, А. A. Brutyan, I. A. Efimova, N. L. Bogdanova

    Изучение взаимосвязи маркеров воспаления в сыворотке крови и рецидивирования фибрилляции предсердий у пациентов, перенесших катетерную изоляцию легочных вен


  • Open Access

    Single-shot cryoablation of an epicardial inferoparaseptal accessory pathway: a case report

    by Karapet V Davtyan, Arpi H Topchyan, Andrey A Kalemberg, Georgiy Yu Simonyan

    Background: Catheter ablation (CA) of epicardial accessory pathways (APs) can be performed via the coronary sinus (CS) system. Variable CS anatomy with complications of former CA procedures inside the CS venous system may require using alternative CA approach and technology. Case summary: We report the case of a 23-year-old man with Wolff–Parkinson–White syndrome and history of aborted sudden cardiac death (SCD) and unsuccessful previous AP radiofrequency ablation (RFA). CS venography during the redo procedure revealed an early CS trifurcation with cardiac veins stenosis, thus with difficulties in maintaining cardiac veins’ access and catheter manoeuvring inside CS venous system. The last office visit with electrocardiogram (ECG) performance was in 3 months after the CA. Neither delta wave on the ECG nor any complaints/adverse health effects was detected at that time. Discussion: Successful CA of epicardial AP in patients with a high risk of SCD is essential. However, CS complex anatomy and changes after former RFA inside it may lead to CS venous system access limitations. Alternative CA approach and technology should be considered to ensure CS venous system cannulation and epicardial AP CA performance.


  • Open Access

    Predictors of sustained isolation of pulmonary vein ostia with cryoballoon ablation using a second-generation cryoballoon Arctic Front Advance

    by K. V. Davtyan, A. Н. Topchyan, A. A. Kalemberg, G. Yu. Simonyan, Г. Ю. Симонян

    Предикторы устойчивой изоляции устьев лёгочных вен при криобаллонной аблации с применением криобаллона второго поколения Arctic Front Advance

  • Open Access

    The role of inflammatory theory in the pathogenesis of atrial fibrillation

    by K. V. Davtyan, A. A. Kalemberg, E. N. Tsareva, O. V. Blagova, M. S. Harlap